Deep Tech Startups

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling. It serves pharmaceutical and life-science researchers as an alternative to animal studies and Caco-2 cell lines, offering ready-to-use kits and custom studies.

6 investors

Anaphite develops a dry battery electrode manufacturing technology that combines electrode materials into a single engineered "Dry Coating Precursor" (DCP) powder optimised for high-speed dry-coating production lines. It works as a development partner with battery OEMs, cell manufacturers, equipment makers, and material suppliers to cut costs and emissions in electrode production.

6 investors

Ancilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them. It develops computational and biological platforms to identify, characterize, and counter viruses within the microbiome (the virome).

6 investors

Antiverse is a techbio company that uses machine learning and cell line engineering to design de novo antibody therapeutics against difficult targets such as G-protein coupled receptors and ion channels. It works with pharmaceutical companies and develops its own internal antibody pipeline across multiple indications.

6 investors

Applied Compute builds proprietary AI agents trained on enterprise-specific workflows and data that continuously improve through real-world usage. The platform helps Fortune 500 companies unlock institutional context and deploy autonomous agents within their own secure environments.

6 investors

Argospace provides launch and transportation services for spacecraft and satellites beyond low Earth orbit (LEO), including cislunar and interplanetary missions. The company operates reusable vehicles with dual-mode propulsion to serve satellite operators, space agencies, and exploration missions.

6 investors

Aromyx develops biosensor technology that replicates human olfactory receptors to measure and quantify odors and flavors for product development, quality control, and consumer targeting across food, beverage, sustainability, and health industries.

6 investors

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease. Its pipeline includes a candidate for Type 1 Myotonic Dystrophy (DM1), a form of muscular dystrophy.

6 investors

Artificial Agency is an AI company applying reinforcement learning to build agent technology for video games, drawing on research and gaming-industry expertise. Its team develops game technology and AI agents for the gaming industry.

6 investors

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.

6 investors

AstroForge builds low-cost spacecraft for tracking and mining metal-rich asteroids in deep space, targeting platinum group metals extraction for industrial and space applications.

6 investors

Astrus develops AI software for analog microchip design, automating the hand-crafted layout of analog circuits used in high-speed interconnects and other critical chip components. The platform serves semiconductor designers and chip manufacturers seeking to accelerate the design of advanced analog circuits.

6 investors

Atomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs. The company applies computational approaches to advance RNA therapeutics.

6 investors

AttoTude develops optical interconnect technology for data centers to support artificial intelligence and exascale computing applications.

6 investors

AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.

6 investors

Avicena develops microLED-based optical interconnect technology, including the LightBundle transceiver ICs that pair microLED emitters and photodetectors with multi-core fiber for high-speed chip-to-chip communications. Its products connect GPU clusters across multiple racks to enable scalable, energy-efficient data center and computing interconnects.

6 investors

Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure. The company also builds a Brain Foundation Model software to decode and interpret neural signals for brain-computer interface applications.

6 investors

Bifrost provides GPU-accelerated simulation and synthetic data generation for physical AI systems, enabling teams to train, test, and evaluate robotic and autonomous systems using photorealistic, multi-modal sensor data.

6 investors

Black Semiconductor develops graphene-based photonics integrated directly onto electronic chips, converting electrical signals to optical signals to enable faster, lower-power chip-to-chip communication. Its CMOS-compatible technology targets data centers and semiconductor manufacturers seeking to overcome bandwidth and latency limits in computing.

6 investors

Brelyon develops headset-free virtual displays using optical and computational techniques to create 3D depth and panoramic imagery for gaming, entertainment, and enterprise applications. The technology delivers a cinema-like experience in a standard monitor form factor.

6 investors

Cache develops a platform for reliable long-term storage and access of biomolecules to support precision medicine and fundamental research. It aims to provide scalable, sustainable, and standardized biomolecule storage.

6 investors

Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor. The company serves patients with chronic neurological and related conditions using bioelectronic medicine technology.

6 investors

Callosum is building heterogeneous AI intelligence, working across the full stack from silicon to algorithms to systems. The company is founded by people bridging neuroscience, computing, and AI.

6 investors

Cambridge Terahertz commercializes terahertz sensor technology based on MIT research, delivering compact on-chip radar systems that use non-ionizing radio waves to create 3D images analyzed by AI. The technology miniaturizes capability previously available only in airport scanners for enterprise security and imaging applications.

6 investors